Now Open for Investment

Own a piece of better rest.

Sambrosa is inspired by a European sister product with 13,500+ reviews — now launching in America. Invest starting at $5/share.

Invest Now

$250 minimum · Preferred stock · Open to everyone

Investing involves risk. Review the offering and the company's SEC filings before investing.

The nighttime syrup people can't stop talking about.

Sambrosa combines a precise low dose of antihistamine (9.78mg vs. the 25mg+ in most options) with 7 organic herbs and real honey. No dyes, no artificial flavors, no groggy mornings. Inspired by its European sister product, now FDA-compliant and manufactured in the U.S.

Sambrosa Night Syrup bottle surrounded by organic herbs and honey
California PoppyHawthornHopsReal HoneyMistletoeOatPassion FlowerWhite Chestnut
The Opportunity

A massive market. A product people love.

50+ million Americans struggle to rest well at night. The market is massive — and growing.

$0B

Nighttime Relief Market

Projected by 2032. Growing every year as 50M+ Americans seek better rest.

2022$29B
2032$54B
European Sister Product
0+

Five-Star Reviews

9/10 stars from 100,000+ customers. The sister product has a strong track record.

U.S. Launch
0+

U.S. Reviews at 4.7 Stars

Growing fast since launch. Momentum building.

0M+

Americans Need Better Rest

Massive addressable market — and most options leave people groggy.

$100M+

Founder's Track Record

John Van Hierden's Green Prairie Group generates $100M+ annually. This isn't his first build.

Sister Product Loved in Europe

100,000+ customers, 9/10 stars from 13,500+ reviews for the European sister product

Launching in America

FDA-compliant, manufactured in U.S. facilities

Founder-led

John Van Hierden, founder of Green Prairie Group ($100M+ annual revenue)

Growing fast

850+ U.S. reviews at 4.7 stars since launch

Sambrosa founding team at conference
The Founder

He found it in Europe. Now he's bringing it to America.

John Van Hierden discovered the formula through a European sister company — a product with 100,000+ customers and 13,500+ five-star reviews. He licensed the formula and launched Sambrosa in the U.S. with FDA-registered manufacturing. This isn't a side project — John is the founder of Green Prairie Group, a company generating $100M+ in annual revenue.

How to Invest

Three steps. That's it.

No complicated paperwork. No accreditation required. Just pick your amount and you're in.

01

Click "Invest Now"

You'll be taken to our secure investment portal on Cultivate Capital.

02

Choose your amount

Starting at $250 (50 shares at $5/share). Open to everyone — not just accredited investors.

03

You're an owner

Receive preferred non-voting stock in Sambrosa Care Inc. plus investor perks.

Plus, every investor gets perks

$250

Get in the door

  • 50 shares at $5/share

$255–$500

Early supporter

  • 10% product discount for 1 year
  • 2 free samples sent to friends/family

$505+

True believer

  • 10% product discount for 2 years
  • 5 free samples sent to friends/family

Every investor receives preferred stock in Sambrosa Care Inc.

850+ five-star reviews

Guaranteed night rest

I love this product. I've recommended it to several friends, and I know at least three of them that are using it regularly.

Sherry V.

Verified Buyer

12/23/25

IT WORKS

Can't believe it. Had such a great day after only one use.

Stephen C.

Verified Buyer

01/25/26

Better than anything

This product works better than anything I have ever tried. It helps me rest well despite the allergies. Don't hesitate to try.

Beverley

Verified Buyer

01/26/26

Only product that helps

I have tried many products. This is the only one, along with melatonin, that consistently helps me rest.

Cara G.

Verified Buyer

03/02/26
I love it, it keeps me asleep longer.

Lisa

Verified Buyer

12/15/25
FDA Registered ManufacturingMade in the USA100,000+ European CustomersFamily-Owned Business

850+ reasons to believe. One chance to invest.

Invest in Sambrosa
Woman resting peacefully with Sambrosa Night Syrup on the nightstand

Own a piece of better rest.

Starting at $5/share. $250 minimum.

Open to everyone — not just accredited investors. Preferred stock with investor perks.

Preferred stock · Investor perks · SEC-filed offering

Access important documents and resources related to your investment opportunity

Cultivate Capital

COPYRIGHT © 2026 Cultivate Capital Group, LLC. All Rights Reserved.

www.CultivateCapitalcf.org is a website owned and operated by Cultivate Capital Group, LLC (“Cultivate Capital”). All Regulation Crowdfunding activities on www.CultivateCapitalcf.org are conducted by Cultivate Capital, a broker-dealer registered with the U.S. Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority (FINRA).

All securities listed on www.CultivateCapitalcf.org are being offered by the applicable issuer of such securities and all information included on this website related to those securities is the responsibility of each such issuer. The information on our website regarding any issuer or in a blog post is based on publicly available information or directly from the subject issuer. Cultivate Capital and its affiliates make no representation or warranty as to the adequacy, accuracy or completeness of such information. Any written materials on our website have been prepared solely for informative purposes and are not a solicitation of an offer to buy or an offer to sell any security. Cultivate Capital does not give investment advice, recommendations, or analysis as to any securities through www.CultivateCapitalcf.org or in any other manner, nor does it endorse or recommend investments in any company or the suitability of an investment for any particular investor. Cultivate Capital does not provide any legal or tax advice with respect to any securities. Neither Cultivate Capital nor any of its officers, directors, agents, registered representatives and/or employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information submitted by or presented. No securities offered on this website have been recommended or approved by any federal or state securities commission or regulatory authority, including but not limited to, the U.S. Securities and Exchange Commission.

By using www.CultivateCapitalcf.org, you accept and agree to be bound by the site's Terms of Use and Privacy Policy as may be amended from time to time without notice or liability. Please be aware that Cultivate Capital or its affiliates receive fees from issuers posted on our website at www.CultivateCapitalcf.org. Details about our compensation are disclosed in the offering materials for each issuer conducting a live offering. Cultivate Capital may choose to compensate outside sources to help market our business and to receive introductions to possible issuers. Compensation to such parties will not be based on the success or size of any transaction and fees will not be based directly or indirectly on the purchase or sale of any security. Blog posts or the posting of information on our website regarding any issuer, including any links to information either in the blog post or on our website, should not be construed as an endorsement or recommendation of that issuer for any purpose whatsoever. Links are provided for information only and Cultivate Capital and its affiliates are not responsible for any information at the sites linked to. Blog posts or the posting of information on our website does not take into account the investment objectives, financial situation or needs of any particular investor, and each investor should consider whether any investment opportunity is appropriate given their investment objectives and current financial circumstances. Any person considering any investment is encouraged to consult with their own investment or financial advisor, tax advisor and/or attorney before making any investment.

All investments entail risk. The issuers on our site are generally small or early-stage companies and are subject to risks inherent in investing in any small or early-stage company as well as other risks specific to their business and operations. In addition, securities of these issuers may be highly illiquid, requiring that they be held for an indefinite period of time or have a limited market for resale. Therefore, no one should invest in any of these issuers unless they have no need for liquidity of their investment and can sustain a total loss of their investment. You should only invest an amount of money that you can afford to lose without changing your lifestyle. You should thoroughly review the complete offering materials for any investment opportunity, particularly all risk factors, prior to investing in any offering and become familiar with the investor requirements, investment limits and your ability to resell the investment.

The information on this website relating to Sambrosa Care, Inc. (“Sambrosa”) was provided by Sambrosa to assist with marketing their Regulation Crowdfunding stock offering. The text on any webpages related to Sambrosa is a summary but does not contain all of the terms of their securities offering. In order to review all of the terms of their securities offering, you should review their Form C and Offering Statement that contains all of the terms, conditions, risk factors, and disclosures that you should read and understand before you invest in their company. Their Form C and Offering Statement is available to download here for you to read and review before you invest. You can also view it on the SEC's website.

The Form C and Offering Statement explains that Sambrosa is offering 200,000 Shares of Preferred Non-Voting stock at $5.00 per share with a minimum purchase of 50 Shares ($250.00). The U.S. Securities and Exchange Commission (SEC) does not pass upon the merits of, or give its approval to, any of the securities that are being offered or the terms of the offering, nor does it pass upon the accuracy or completeness of the Form C and Offering Statement, other selling literature or this website. The securities Sambrosa are offering are offered pursuant to an exemption from registration with the SEC; however, the SEC has not made an independent determination that the securities offered in their Form C and Offering Statement and in their offering are exempt from registration. When you review their Form C and Offering Statement, please review all of the risk factors before making an investment in their company. An investment in Sambrosa should only be made if you are capable of evaluating the risks and merits of this investment and if you have sufficient resources to bear the entire loss of your investment, should that occur.

If you are an accredited investor, you have no limitation on the amount you may invest. If you are not an accredited investor, then the amount you may invest is limited by Regulation Crowdfunding. These limitations provide that if either your income or net worth is less than $124,000, you can invest the greater of $2,500 or 5% of your higher income or net worth figure. If either your income or net worth is $124,000 greater, you may invest up to 10% of the larger value. Regardless of income or net worth, all non-accredited investors are subject to a $124,000 ceiling on total Regulation Crowdfunding investments within a 12-month span.

For general information on investing, we encourage you to review www.investor.gov. Sambrosa's Form C and Offering Statement does not constitute an offer or solicitation in any jurisdiction in which such an offer or solicitation would be unlawful. No person has been authorized to give any information or to make any representations concerning Sambrosa other than those contained in their Form C and Offering Statement, and if given or made, such other information or representation must not be relied upon. Prospective investors are not to construe the contents of Sambrosa's Form C and Offering Statement, or of any prior or subsequent communications from Sambrosa or any of its employees, agents or affiliates, or on this website as investment, legal, financial or tax advice. Before investing in Sambrosa's offering, please review their Form C and Offering Statement carefully, ask any questions of the company's management that you would like answered and consult your own counsel, accountant and other professional advisors as to legal, tax and other related matters concerning the investment.